Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer.

Alanee S, Shah S, Vijai J, Schrader K, Hamilton R, Rau-Murthy R, Sarrel K, Manschreck C, Eastham J, Offit K.

Fam Cancer. 2013 Dec;12(4):597-600. doi: 10.1007/s10689-013-9618-y.

2.

Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.

Kote-Jarai Z, Mikropoulos C, Leongamornlert DA, Dadaev T, Tymrakiewicz M, Saunders EJ, Jones M, Jugurnauth-Little S, Govindasami K, Guy M, Hamdy FC, Donovan JL, Neal DE, Lane JA, Dearnaley D, Wilkinson RA, Sawyer EJ, Morgan A, Antoniou AC, Eeles RA; UK Genetic Prostate Cancer Study Collaborators, and ProtecT Study Group.

Ann Oncol. 2015 Apr;26(4):756-61. doi: 10.1093/annonc/mdv004. Epub 2015 Jan 16.

PMID:
25595936
3.

Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.

Beebe-Dimmer JL, Isaacs WB, Zuhlke KA, Yee C, Walsh PC, Isaacs SD, Johnson AM, Ewing CE, Humphreys EB, Chowdhury WH, Montie JE, Cooney KA.

BJU Int. 2014 May;113(5):830-5. doi: 10.1111/bju.12522. Epub 2014 Mar 5.

4.

A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.

Karlsson R, Aly M, Clements M, Zheng L, Adolfsson J, Xu J, Grönberg H, Wiklund F.

Eur Urol. 2014 Jan;65(1):169-76. doi: 10.1016/j.eururo.2012.07.027. Epub 2012 Jul 20.

PMID:
22841674
5.

HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.

Laitinen VH, Wahlfors T, Saaristo L, Rantapero T, Pelttari LM, Kilpivaara O, Laasanen SL, Kallioniemi A, Nevanlinna H, Aaltonen L, Vessella RL, Auvinen A, Visakorpi T, Tammela TL, Schleutker J.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):452-60. doi: 10.1158/1055-9965.EPI-12-1000-T. Epub 2013 Jan 4.

6.

HOXB13 mutation and prostate cancer: studies of siblings and aggressive disease.

Witte JS, Mefford J, Plummer SJ, Liu J, Cheng I, Klein EA, Rybicki BA, Casey G.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):675-80. doi: 10.1158/1055-9965.EPI-12-1154. Epub 2013 Feb 8.

7.

Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.

Schroeck FR, Zuhlke KA, Siddiqui J, Siddiqui R, Cooney KA, Wei JT.

J Urol. 2013 Mar;189(3):849-53. doi: 10.1016/j.juro.2012.09.117. Epub 2012 Oct 2.

8.

The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.

Beebe-Dimmer JL, Hathcock M, Yee C, Okoth LA, Ewing CM, Isaacs WB, Cooney KA, Thibodeau SN.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1366-72. doi: 10.1158/1055-9965.EPI-15-0247. Epub 2015 Jun 24.

9.

Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness.

Storebjerg TM, Høyer S, Kirkegaard P, Bro F; LuCamp Study Group, Ørntoft TF, Borre M, Sørensen KD.

BJU Int. 2016 Oct;118(4):646-53. doi: 10.1111/bju.13416. Epub 2016 Feb 12.

PMID:
26779768
10.

Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort.

Hoffmann TJ, Sakoda LC, Shen L, Jorgenson E, Habel LA, Liu J, Kvale MN, Asgari MM, Banda Y, Corley D, Kushi LH, Quesenberry CP Jr, Schaefer C, Van Den Eeden SK, Risch N, Witte JS.

PLoS Genet. 2015 Jan 28;11(1):e1004930. doi: 10.1371/journal.pgen.1004930. eCollection 2015 Jan. Erratum in: PLoS Genet. 2015 Jun;11(6):e1005362. PLoS Genet. 2015 Apr;11(4):e1005114.

11.

Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer.

Breyer JP, Avritt TG, McReynolds KM, Dupont WD, Smith JR.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1348-53. doi: 10.1158/1055-9965.EPI-12-0495. Epub 2012 Jun 19.

12.

HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.

Smith SC, Palanisamy N, Zuhlke KA, Johnson AM, Siddiqui J, Chinnaiyan AM, Kunju LP, Cooney KA, Tomlins SA.

Am J Surg Pathol. 2014 May;38(5):615-26. doi: 10.1097/PAS.0000000000000090.

13.

Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer.

Handorf E, Crumpler N, Gross L, Giri VN.

J Genet Couns. 2014 Jun;23(3):371-6. doi: 10.1007/s10897-013-9672-5. Epub 2013 Dec 7.

14.

HOXB13 mutations in a population-based, case-control study of prostate cancer.

Stott-Miller M, Karyadi DM, Smith T, Kwon EM, Kolb S, Stanford JL, Ostrander EA.

Prostate. 2013 May;73(6):634-41. doi: 10.1002/pros.22604. Epub 2012 Nov 5.

15.

Association between germline HOXB13 G84E mutation and risk of prostate cancer.

Akbari MR, Trachtenberg J, Lee J, Tam S, Bristow R, Loblaw A, Narod SA, Nam RK.

J Natl Cancer Inst. 2012 Aug 22;104(16):1260-2. doi: 10.1093/jnci/djs288. Epub 2012 Jul 9.

PMID:
22781434
16.

The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland.

Kluźniak W, Wokołorczyk D, Kashyap A, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Dębniak T, Gołąb A, Gliniewicz B, Sikorski A, Switała J, Borkowski T, Borkowski A, Antczak A, Wojnar L, Przybyła J, Sosnowski M, Małkiewicz B, Zdrojowy R, Sikorska-Radek P, Matych J, Wilkosz J, Różański W, Kiś J, Bar K, Bryniarski P, Paradysz A, Jersak K, Niemirowicz J, Słupski P, Jarzemski P, Skrzypczyk M, Dobruch J, Domagała P, Akbari MR, Lubiński J, Narod SA, Cybulski C; Polish Hereditary Prostate Cancer Consortium.

Prostate. 2013 Apr;73(5):542-8. doi: 10.1002/pros.22594. Epub 2013 Jan 17.

PMID:
23334858
17.

Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients.

Maia S, Cardoso M, Pinto P, Pinheiro M, Santos C, Peixoto A, Bento MJ, Oliveira J, Henrique R, Jerónimo C, Teixeira MR.

PLoS One. 2015 Jul 15;10(7):e0132728. doi: 10.1371/journal.pone.0132728. eCollection 2015.

18.

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.

Nastiuk KL, Mansukhani M, Terry MB, Kularatne P, Rubin MA, Melamed J, Gammon MD, Ittmann M, Krolewski JJ.

Prostate. 1999 Aug 1;40(3):172-7.

19.

A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men.

Lin X, Qu L, Chen Z, Xu C, Ye D, Shao Q, Wang X, Qi J, Chen Z, Zhou F, Wang M, Wang Z, He D, Wu D, Gao X, Yuan J, Wang G, Xu Y, Wang G, Dong P, Jiao Y, Yang J, Ou-Yang J, Jiang H, Zhu Y, Ren S, Zhang Z, Yin C, Wu Q, Zheng Y, Turner AR, Tao S, Na R, Ding Q, Lu D, Shi R, Sun J, Liu F, Zheng SL, Mo Z, Sun Y, Xu J.

Prostate. 2013 Jan;73(2):169-75. doi: 10.1002/pros.22552. Epub 2012 Jun 21.

20.

G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis.

Huang H, Cai B.

Tumour Biol. 2014 Feb;35(2):1177-82. doi: 10.1007/s13277-013-1157-5. Epub 2013 Sep 13.

PMID:
24026887

Supplemental Content

Support Center